Page 6 - Y Mabs Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Y-mAbs Therapeutics (NASDAQ:YMAB) Trading Up 4%

Y-mAbs Therapeutics (NASDAQ:YMAB) Trading Up 4%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesY mabs therapeutics incTower research capitalLazard asset managementChina universal asset management coCanaccord genuity groupRussell investments group ltdY mabs therapeuticsGet free reportAbs therapeuticsResearch capitalUniversal asset managementInvestments groupAsset managementY mabs therapeutics daily

Y-mAbs Therapeutics (NASDAQ:YMAB) Shares Down 3 2%

Y-mAbs Therapeutics (NASDAQ:YMAB) Shares Down 3 2%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesCanaccord genuity groupY mabs therapeutics company profileRice hall james associatesSwiss national bankJpmorgan chase coMetlife investment managementY mabs therapeutics incBlackrock incY mabs therapeuticsGet free reportGenuity groupAbs therapeuticsHall jamesNational bankLife investment management

Y-mAbs Therapeutics (NASDAQ:YMAB) Shares Gap Down to $16 19

Y-mAbs Therapeutics (NASDAQ:YMAB) Shares Gap Down to $16 19
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesPolar capital holdings plcMillennium managementBlackrock incCanaccord genuity groupVanguard group incY mabs therapeutics incY mabs therapeuticsGet free reportAbs therapeuticsGenuity groupCapital holdings plcStreet corpY mabs therapeutics daily

Y-mAbs Therapeutics (NASDAQ:YMAB) Stock Price Up 5 9%

Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Get Free Report)’s stock price rose 5.9% during mid-day trading on Monday . The company traded as high as $17.49 and last traded at $17.22. Approximately 119,509 shares changed hands during mid-day trading, a decline of 71% from the average daily volume of 406,738 shares. The stock had previously closed […]

United statesNuveen asset managementCanaccord genuity groupVanguard group incY mabs therapeutics company profileGoldman sachs group incY mabs therapeutics incBarclays plcPricet rowe associates incY mabs therapeuticsGet free reportAbs therapeuticsSachs groupAsset managementY mabs therapeutics dailyNasdaq ymab

Y-mAbs Therapeutics (NASDAQ:YMAB) Shares Up 3 9%

Y-mAbs Therapeutics (NASDAQ:YMAB) Shares Up 3 9%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesAcadian asset managementCapital partnersCanaccord genuity groupMassachusetts financial services coY mabs therapeutics company profileY mabs therapeutics incExchange traded conceptsY mabs therapeuticsGet free reportGenuity groupAbs therapeuticsAsset managementFinancial servicesTraded conceptsY mabs therapeutics daily